Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Signorovitch

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Pediatric Pulmonology|December 21, 2012
A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended careGregory S Sawicki, Rajeev Ayyagari, Jie Zhang, et al.
Blood Advances|April 10, 2020
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trialRichard T Maziarz, Stephen J Schuster, Vadim V Romanov, et al.
Current Medical Research and Opinion|January 9, 2016
Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart reviewNicholas J Vogelzang, Sumanta K Pal, James E Signorovitch, et al.
Blood Advances|April 10, 2020
Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trialStephen J Schuster, Richard T Maziarz, Elisha S Rusch, et al.
Current Medical Research and Opinion|December 10, 2009
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacinJames E Signorovitch, Mei Sheng Duh, Anirban Sengupta, et al.
Leukemia & Lymphoma|March 31, 2025
Real-world treatment patterns, healthcare resource use, and costs among patients with diffuse large B-cell lymphoma: a retrospective analysis of US claims dataMahek Garg, Ambika Satija, Yan Song, et al.
Urology|March 7, 2017
Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related AngiomyolipomasElyse Swallow, Sarah King, Jinlin Song, et al.
Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Cancer|September 12, 2018
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trialMeletios A Dimopoulos, Sagar Lonial, Keith A Betts, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Pediatric Pulmonology|December 21, 2012
A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended careGregory S Sawicki, Rajeev Ayyagari, Jie Zhang, et al.
Blood Advances|April 10, 2020
Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trialRichard T Maziarz, Stephen J Schuster, Vadim V Romanov, et al.
Current Medical Research and Opinion|January 9, 2016
Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart reviewNicholas J Vogelzang, Sumanta K Pal, James E Signorovitch, et al.
Blood Advances|April 10, 2020
Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trialStephen J Schuster, Richard T Maziarz, Elisha S Rusch, et al.
Current Medical Research and Opinion|December 10, 2009
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacinJames E Signorovitch, Mei Sheng Duh, Anirban Sengupta, et al.
Leukemia & Lymphoma|March 31, 2025
Real-world treatment patterns, healthcare resource use, and costs among patients with diffuse large B-cell lymphoma: a retrospective analysis of US claims dataMahek Garg, Ambika Satija, Yan Song, et al.
Urology|March 7, 2017
Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related AngiomyolipomasElyse Swallow, Sarah King, Jinlin Song, et al.
Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Cancer|September 12, 2018
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trialMeletios A Dimopoulos, Sagar Lonial, Keith A Betts, et al.
Pageof 5